Literature DB >> 14727129

The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.

Nicole Stupka1, Paul Gregorevic, David R Plant, Gordon S Lynch.   

Abstract

Although mdx mice share the same genetic defect and lack dystrophin expression as in Duchenne muscular dystrophy (DMD), their limb muscles have a high regenerative capacity that ensures a more benign phenotype and essentially normal function. The cellular pathways responsible for this enhanced regenerative capacity are unknown. We tested the hypothesis that the calcineurin signal transduction pathway is essential for the successful regeneration following severe degeneration observed in the limb muscles of young mdx mice (2-4 weeks old) and that inhibition of this pathway using cyclosporine A (CsA) would exacerbate the dystrophic pathology. Eighteen-day-old mdx and C57BL/10 mice were treated with CsA for 16 days. CsA administration severely disrupted muscle regeneration in mdx mice, but had minimal effect in C57BL/10 mice. Muscles from CsA-treated mdx mice had fewer centrally nucleated fibers and extensive collagen, connective tissue, and mononuclear cell infiltration than muscles from vehicle-treated littermates. The deleterious effects of CsA on muscle morphology were accompanied by a 30-35% decrease in maximal force producing capacity. Taken together, these observations indicate that the calcineurin signal transduction pathway is a significant determinant of successful skeletal muscle regeneration in young mdx mice. Up-regulating this pathway may have clinical significance for DMD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14727129     DOI: 10.1007/s00401-003-0807-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Sarcolipin deletion in mdx mice impairs calcineurin signalling and worsens dystrophic pathology.

Authors:  Val A Fajardo; Paige J Chambers; Emma S Juracic; Bradley A Rietze; Daniel Gamu; Catherine Bellissimo; Frenk Kwon; Joe Quadrilatero; A Russell Tupling
Journal:  Hum Mol Genet       Date:  2018-12-01       Impact factor: 6.150

2.  Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice.

Authors:  Leah J Harcourt; Anna Greer Holmes; Paul Gregorevic; Jonathan D Schertzer; Nicole Stupka; David R Plant; Gordon S Lynch
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

3.  Myoferlin regulation by NFAT in muscle injury, regeneration and repair.

Authors:  Alexis R Demonbreun; Karen A Lapidos; Konstantina Heretis; Samantha Levin; Rodney Dale; Peter Pytel; Eric C Svensson; Elizabeth M McNally
Journal:  J Cell Sci       Date:  2010-06-22       Impact factor: 5.285

4.  A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice.

Authors:  Annamaria De Luca; Beatrice Nico; Antonella Liantonio; Maria Paola Didonna; Bodvael Fraysse; Sabata Pierno; Rosa Burdi; Domenica Mangieri; Jean-François Rolland; Claudia Camerino; Alberta Zallone; Paolo Confalonieri; Francesca Andreetta; Elisa Arnoldi; Isabelle Courdier-Fruh; Josef P Magyar; Antonio Frigeri; Michela Pisoni; Maria Svelto; Diana Conte Camerino
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

Review 5.  The functional role of calcineurin in hypertrophy, regeneration, and disorders of skeletal muscle.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-04-01

6.  Green tea extract decreases muscle pathology and NF-kappaB immunostaining in regenerating muscle fibers of mdx mice.

Authors:  Nicholas P Evans; Jarrod A Call; Josep Bassaganya-Riera; John L Robertson; Robert W Grange
Journal:  Clin Nutr       Date:  2009-11-07       Impact factor: 7.324

Review 7.  Therapeutic targeting of signaling pathways in muscular dystrophy.

Authors:  Shephali Bhatnagar; Ashok Kumar
Journal:  J Mol Med (Berl)       Date:  2009-10-09       Impact factor: 4.599

Review 8.  Therapeutics in duchenne muscular dystrophy.

Authors:  Jonathan B Strober
Journal:  NeuroRx       Date:  2006-04

Review 9.  Wasting mechanisms in muscular dystrophy.

Authors:  Jonghyun Shin; Marjan M Tajrishi; Yuji Ogura; Ashok Kumar
Journal:  Int J Biochem Cell Biol       Date:  2013-05-11       Impact factor: 5.085

10.  Investigation of Debio 025, a cyclophilin inhibitor, in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy.

Authors:  J Reutenauer; O M Dorchies; O Patthey-Vuadens; G Vuagniaux; U T Ruegg
Journal:  Br J Pharmacol       Date:  2008-07-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.